- Home
- GALT vs GOODN Comparison
GALT vs GOODN Comparison
Compare GALT & GOODN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GALT | GOODN |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 297.0M | N/A |
| IPO Year | 2008 | 2003 |
Fundamental Metrics
Financial Performance| Metric | GALT | GOODN |
|---|---|---|
| Price | $3.43 | $23.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 376.1K | 2.6K |
| Earning Date | 05-15-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.84 | N/A |
| EPS | N/A | ★ 0.18 |
| Revenue | N/A | ★ $161,336,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $131.94 |
| Revenue Growth | N/A | ★ 8.00 |
| 52 Week Low | $2.03 | $20.91 |
| 52 Week High | $7.13 | $23.91 |
Technical Indicators
Market Signals| Indicator | GALT | GOODN |
|---|---|---|
| Relative Strength Index (RSI) | 49.20 | 62.62 |
| Support Level | $2.74 | $21.97 |
| Resistance Level | $4.35 | $23.83 |
| Average True Range (ATR) | 0.28 | 0.24 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 79.55 | 85.97 |
Price Performance
Historical ComparisonAbout GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About GOODN Gladstone Commercial Corporation
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.